0001209191-22-034895.txt : 20220607
0001209191-22-034895.hdr.sgml : 20220607
20220607181708
ACCESSION NUMBER: 0001209191-22-034895
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220603
FILED AS OF DATE: 20220607
DATE AS OF CHANGE: 20220607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Verstandig Grant
CENTRAL INDEX KEY: 0001843817
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40045
FILM NUMBER: 221002188
MAIL ADDRESS:
STREET 1: C/O NEXIMMUNE, INC.
STREET 2: 9119 GAITHER ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20877
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NexImmune, Inc.
CENTRAL INDEX KEY: 0001538210
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9119 GAITHER ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 301-825-9810
MAIL ADDRESS:
STREET 1: 9119 GAITHER ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-03
0
0001538210
NexImmune, Inc.
NEXI
0001843817
Verstandig Grant
C/O NEXIMMUNE, INC.
9119 GAITHER ROAD
GAITHERSBURG
MD
20877
1
0
0
0
Common Stock
2022-06-07
4
P
0
26876
2.284
A
1105495
D
Common Stock
2022-06-06
4
P
0
25000
2.1415
A
1078619
D
Common Stock
2022-06-03
4
P
0
15000
2.2249
A
1053619
D
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.14 to $2.45, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
Excludes 17,376 shares of common stock underlying options that are currently exercisable.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.06 to $2.28, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.13 to $2.30, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
/s/ Andrew Pearce, Attorney-in-fact
2022-06-07